Palisade Net Debt vs Cash And Short Term Investments Analysis

PALI Stock

USD 6.36 0.10 1.55%

Palisade Bio financial indicator trend analysis is much more than just breaking down Palisade Bio prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Palisade Bio is a good investment. Please check the relationship between Palisade Bio Net Debt and its Cash And Short Term Investments accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Palisade Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.

For more detail on how to invest in Palisade Stock please use our How to Invest in Palisade Bio guide.

Net Debt vs Cash And Short Term Investments

Net Debt vs Cash And Short Term Investments Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Palisade Bio Net Debt account and Cash And Short Term Investments. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between Palisade Bio's Net Debt and Cash And Short Term Investments is -0.36. Overlapping area represents the amount of variation of Net Debt that can explain the historical movement of Cash And Short Term Investments in the same time period over historical financial statements of Palisade Bio, assuming nothing else is changed. The correlation between historical values of Palisade Bio's Net Debt and Cash And Short Term Investments is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Debt of Palisade Bio are associated (or correlated) with its Cash And Short Term Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash And Short Term Investments has no effect on the direction of Net Debt i.e., Palisade Bio's Net Debt and Cash And Short Term Investments go up and down completely randomly.

Correlation Coefficient

-0.36

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Net Debt

The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.

Cash And Short Term Investments

Short Term Investments is an account in the current assets section of Palisade Bio balance sheet. This account contains Palisade Bio investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Palisade Bio fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.

Most indicators from Palisade Bio's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Palisade Bio current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Palisade Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.

For more detail on how to invest in Palisade Stock please use our How to Invest in Palisade Bio guide.As of now, Palisade Bio's Enterprise Value Multiple is increasing as compared to previous years.

	2021	2023	2024 (projected)
Reconciled Depreciation	2K	4K	3.3K
Cost Of Revenue	168K	4K	3.8K

Reconciled Depreciation Cost Of Revenue

Palisade Bio fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Net Receivables
Total Assets		0.4	-0.14	0.37	0.75	0.4	0.05	-0.35	-0.35	0.29	0.82	0.39	-0.13	1.0	0.39	0.11	0.32	-0.03	0.43	0.36	0.56	1.0	0.22	0.56	0.39	0.2
Short Long Term Debt Total	0.4		0.16	0.38	0.18	0.56	-0.29	0.34	0.02	0.26	0.17	0.45	-0.25	0.4	0.91	-0.42	0.26	-0.2	-0.01	0.34	0.56	0.37	0.76	0.73	0.91	-0.33
Other Current Liab	-0.14	0.16		0.58	-0.56	0.38	0.12	0.09	0.43	0.55	-0.05	0.47	0.72	-0.17	-0.02	0.03	0.51	0.45	-0.48	0.58	-0.16	-0.18	0.22	-0.16	-0.1	-0.15
Total Current Liabilities	0.37	0.38	0.58		-0.27	0.62	-0.09	0.17	0.03	0.75	0.24	0.75	0.57	0.33	0.27	-0.09	0.72	0.48	-0.07	0.89	0.15	0.33	0.62	0.27	0.21	-0.14
Total Stockholder Equity	0.75	0.18	-0.56	-0.27		0.05	0.17	-0.56	-0.4	-0.31	0.73	-0.16	-0.6	0.77	0.21	0.25	-0.35	-0.36	0.5	-0.34	0.61	0.78	-0.04	0.39	0.25	0.32
Property Plant And Equipment Net	0.4	0.56	0.38	0.62	0.05		-0.03	0.14	-0.15	0.54	0.18	0.65	0.24	0.35	0.4	0.17	0.33	0.36	0.14	0.48	0.74	0.36	0.55	0.39	0.33	0.16
Current Deferred Revenue	0.05	-0.29	0.12	-0.09	0.17	-0.03		-0.44	0.09	-0.33	0.22	-0.17	0.12	0.07	-0.25	0.48	-0.28	-0.1	-0.06	-0.24	0.02	0.06	-0.25	-0.4	-0.27	-0.02
Net Debt	-0.35	0.34	0.09	0.17	-0.56	0.14	-0.44		0.09	0.22	-0.74	0.22	0.06	-0.36	0.42	-0.58	0.38	-0.02	-0.17	0.32	-0.13	-0.38	0.3	0.22	0.42	-0.4
Retained Earnings	-0.35	0.02	0.43	0.03	-0.4	-0.15	0.09	0.09		0.14	-0.21	-0.33	0.25	-0.34	0.08	0.22	0.06	0.32	-0.99	0.05	-0.39	-0.34	-0.06	-0.61	0.01	-0.03
Accounts Payable	0.29	0.26	0.55	0.75	-0.31	0.54	-0.33	0.22	0.14		0.07	0.63	0.66	0.25	0.13	-0.05	0.83	0.6	-0.18	0.86	-0.02	0.25	0.27	0.13	0.05	0.08
Cash	0.82	0.17	-0.05	0.24	0.73	0.18	0.22	-0.74	-0.21	0.07		0.16	-0.1	0.82	0.13	0.32	0.03	0.01	0.29	0.13	0.42	0.83	0.11	0.29	0.13	0.26
Non Current Assets Total	0.39	0.45	0.47	0.75	-0.16	0.65	-0.17	0.22	-0.33	0.63	0.16		0.54	0.35	0.33	-0.22	0.7	0.15	0.29	0.77	0.24	0.33	0.46	0.58	0.29	-0.05
Non Currrent Assets Other	-0.13	-0.25	0.72	0.57	-0.6	0.24	0.12	0.06	0.25	0.66	-0.1	0.54		-0.17	-0.29	0.23	0.62	0.61	-0.31	0.64	-0.4	-0.17	-0.08	-0.32	-0.39	0.2
Cash And Short Term Investments	1.0	0.4	-0.17	0.33	0.77	0.35	0.07	-0.36	-0.34	0.25	0.82	0.35	-0.17		0.4	0.08	0.29	-0.1	0.42	0.33	0.54	1.0	0.2	0.56	0.4	0.15
Common Stock Total Equity	0.39	0.91	-0.02	0.27	0.21	0.4	-0.25	0.42	0.08	0.13	0.13	0.33	-0.29	0.4		-0.35	0.26	-0.17	-0.06	0.29	0.45	0.38	0.61	0.65	0.99	-0.25
Common Stock Shares Outstanding	0.11	-0.42	0.03	-0.09	0.25	0.17	0.48	-0.58	0.22	-0.05	0.32	-0.22	0.23	0.08	-0.35		-0.32	0.51	-0.17	-0.25	0.19	0.13	-0.37	-0.58	-0.44	0.8
Non Current Liabilities Total	0.32	0.26	0.51	0.72	-0.35	0.33	-0.28	0.38	0.06	0.83	0.03	0.7	0.62	0.29	0.26	-0.32		0.38	-0.11	0.95	-0.2	0.27	0.18	0.26	0.2	-0.17
Other Current Assets	-0.03	-0.2	0.45	0.48	-0.36	0.36	-0.1	-0.02	0.32	0.6	0.01	0.15	0.61	-0.1	-0.17	0.51	0.38		-0.35	0.45	-0.07	-0.05	-0.02	-0.41	-0.29	0.48
Other Stockholder Equity	0.43	-0.01	-0.48	-0.07	0.5	0.14	-0.06	-0.17	-0.99	-0.18	0.29	0.29	-0.31	0.42	-0.06	-0.17	-0.11	-0.35		-0.1	0.44	0.42	0.04	0.62	0.01	0.07
Total Liab	0.36	0.34	0.58	0.89	-0.34	0.48	-0.24	0.32	0.05	0.86	0.13	0.77	0.64	0.33	0.29	-0.25	0.95	0.45	-0.1		-0.06	0.32	0.39	0.3	0.23	-0.17
Property Plant And Equipment Gross	0.56	0.56	-0.16	0.15	0.61	0.74	0.02	-0.13	-0.39	-0.02	0.42	0.24	-0.4	0.54	0.45	0.19	-0.2	-0.07	0.44	-0.06		0.56	0.48	0.54	0.45	0.2
Total Current Assets	1.0	0.37	-0.18	0.33	0.78	0.36	0.06	-0.38	-0.34	0.25	0.83	0.33	-0.17	1.0	0.38	0.13	0.27	-0.05	0.42	0.32	0.56		0.19	0.53	0.38	0.21
Short Term Debt	0.22	0.76	0.22	0.62	-0.04	0.55	-0.25	0.3	-0.06	0.27	0.11	0.46	-0.08	0.2	0.61	-0.37	0.18	-0.02	0.04	0.39	0.48	0.19		0.58	0.61	-0.37
Intangible Assets	0.56	0.73	-0.16	0.27	0.39	0.39	-0.4	0.22	-0.61	0.13	0.29	0.58	-0.32	0.56	0.65	-0.58	0.26	-0.41	0.62	0.3	0.54	0.53	0.58		0.71	-0.27
Common Stock	0.39	0.91	-0.1	0.21	0.25	0.33	-0.27	0.42	0.01	0.05	0.13	0.29	-0.39	0.4	0.99	-0.44	0.2	-0.29	0.01	0.23	0.45	0.38	0.61	0.71		-0.33
Net Receivables	0.2	-0.33	-0.15	-0.14	0.32	0.16	-0.02	-0.4	-0.03	0.08	0.26	-0.05	0.2	0.15	-0.25	0.8	-0.17	0.48	0.07	-0.17	0.2	0.21	-0.37	-0.27	-0.33

Click cells to compare fundamentals

Palisade Bio Account Relationship Matchups

Palisade Bio fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	6.6M	3.0M	12.5M	15.8M	14.1M	12.3M
Other Current Liab	368.0K	3.3M	779K	991K	1.6M	1.0M
Total Current Liabilities	1.2M	8.1M	2.5M	3.0M	2.6M	3.4M
Total Stockholder Equity	5.1M	(16.6M)	7.4M	12.5M	11.3M	6.2M
Property Plant And Equipment Net	242.7K	280K	112K	310K	208K	233.1K
Net Debt	(4.9M)	708K	(10.3M)	(12.0M)	(12.1M)	(11.5M)
Retained Earnings	(222.0M)	(68.0M)	(94.6M)	(109.2M)	(121.5M)	(127.6M)
Accounts Payable	824.4K	3.6M	1.5M	1.8M	698K	663.1K
Cash	5.1M	713K	10.5M	12.4M	12.4M	8.5M
Non Current Assets Total	937.0K	2.1M	138K	1.0M	836K	1.1M
Non Currrent Assets Other	25.3K	1.8M	26K	694K	602K	326.6K
Cash And Short Term Investments	5.1M	713K	10.5M	12.4M	12.4M	10.4M
Common Stock Total Equity	151.6K	182.1K	38.7K	173.0K	155.7K	147.9K
Common Stock Shares Outstanding	7.3K	55.5K	187.0K	880.3K	456.0K	478.8K
Liabilities And Stockholders Equity	6.6M	3.0M	12.5M	15.8M	14.1M	12.3M
Non Current Liabilities Total	233.1K	11.5M	2.7M	272K	153K	145.4K
Other Current Assets	510.9K	2.4M	1.9M	2.4M	636K	822.0K
Other Stockholder Equity	227.1M	51.4M	101.9M	121.6M	132.7M	139.7M
Total Liab	1.5M	19.6M	5.1M	3.3M	2.7M	2.6M
Property Plant And Equipment Gross	268.1K	10.8K	112K	310K	208K	218.2K
Total Current Assets	5.6M	896K	12.4M	14.7M	13.2M	11.2M
Intangible Assets	883.5K	763.5K	668.9K	147.1K	169.2K	160.7K
Common Stock	38.7K	28K	143K	30K	93K	88.4K
Net Receivables	21.1K	59K	150K	1.4M	148K	264.5K
Other Assets	13.9K	24.0K	26K	157.6K	29.9K	48.2K
Capital Surpluse	217.1M	219.5M	227.1M	247.8M	285.0M	245.4M
Property Plant Equipment	5K	420K	280K	112K	100.8K	167.9K

Currently Active Assets on Macroaxis

C	Citigroup
CRM	Salesforce
MSFT	Microsoft
V	Visa Class A
GOOG	Alphabet Inc Class C

When determining whether Palisade Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Palisade Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Palisade Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Palisade Bio Stock:

How To Invest In Palisade

Details

Is Palisade Stock a good investment?

Details

What is Palisade Bio's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Palisade Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.

For more detail on how to invest in Palisade Stock please use our How to Invest in Palisade Bio guide.

You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Complementary Tools for Palisade Stock analysis

When running Palisade Bio's price analysis, check to measure Palisade Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Palisade Bio is operating at the current time. Most of Palisade Bio's value examination focuses on studying past and present price action to predict the probability of Palisade Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Palisade Bio's price. Additionally, you may evaluate how the addition of Palisade Bio to your portfolios can decrease your overall portfolio volatility.

	Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon
	Commodity Channel Use Commodity Channel Index to analyze current equity momentum
	Content Syndication Quickly integrate customizable finance content to your own investment portal
	CEOs Directory Screen CEOs from public companies around the world
	Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
	Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios
	Global Correlations Find global opportunities by holding instruments from different markets
	Performance Analysis Check effects of mean-variance optimization against your current asset allocation

Is Palisade Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Palisade Bio. If investors know Palisade will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Palisade Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(27.00)

Revenue Per Share

0.548

Return On Assets

(0.54)

Return On Equity

(1.03)

The market value of Palisade Bio is measured differently than its book value, which is the value of Palisade that is recorded on the company's balance sheet. Investors also form their own opinion of Palisade Bio's value that differs from its market value or its book value, called intrinsic value, which is Palisade Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Palisade Bio's market value can be influenced by many factors that don't directly affect Palisade Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Palisade Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Palisade Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Palisade Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Palisade Net Debt vs Cash And Short Term Investments Analysis

Net Debt vs Cash And Short Term Investments

Net Debt vs Cash And Short Term Investments Correlation Analysis

Correlation Coefficient

Net Debt

Cash And Short Term Investments

Palisade Bio fundamental ratios Correlations

Palisade Bio Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Palisade Bio fundamental ratios Accounts

Currently Active Assets on Macroaxis

Complementary Tools for Palisade Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Cash And Short Term Investments
Common Stock	+ 0.99	Common Stock Total Equity
Total Liab	+ 0.95	Non Current Liabilities Total
Common Stock Total Equity	+ 0.91	Short Long Term Debt Total

Other Stockholder Equity	- 0.99	Retained Earnings
Cash	- 0.74	Net Debt
Intangible Assets	- 0.61	Retained Earnings
Non Currrent Assets Other	- 0.6	Total Stockholder Equity
Intangible Assets	- 0.58	Common Stock Shares Outstanding
Common Stock Shares Outstanding	- 0.58	Net Debt